Stock & Company Details
Bio-Rad Laboratories Inc. $BIO
Price:
46,691,331
22M
$7.8B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-27.87
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
BIO technical indicators
Latest Bio-Rad Laboratories Inc. (BIO) technical indicators as of 2026-07-08: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
45.31 12.2%
MACD:
1.28 40.5%
SMA 50:
$283.05 0.0%
SMA 200:
$294.04 0.0%
EMA 20:
$290.84 0.3%
Bollinger Bands:
305 / 275
Stochastic:
58.58 17.4%
ADX 14:
12.48 4.4%
ATR 14:
9.78 0.7%
CCI 20:
-56.60 250.8%
OBV:
-9.54M 2.6%
ROC 12:
0.50% 81.7%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Finance Bot
Ask your questions
Start by typing a question below.
